Net loss of Mangalam Drugs and Organics reported to Rs 7.35 crore in the quarter ended September 2025 as against net profit of Rs 2.69 crore during the previous quarter ended September 2024. Sales declined 38.23% to Rs 49.26 crore in the quarter ended September 2025 as against Rs 79.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales49.2679.75 -38 OPM %-5.7710.91 - PBDT-7.845.17 PL PBT-12.471.20 PL NP-7.352.69 PL Powered by Capital Market - Live News

Mangalam Drugs and Organics has postponed the meeting of the Board of Directors which was scheduled to be held on 13 November 2025. The meeting will now be held on 20 November 2025.Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 5 September 2025.Powered by Capital Market - Live News

Net loss of Mangalam Drugs and Organics reported to Rs 13.80 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore during the previous quarter ended June 2024. Sales declined 25.21% to Rs 57.21 crore in the quarter ended June 2025 as against Rs 76.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales57.2176.49 -25 OPM %-7.8310.71 - PBDT-8.524.46 PL PBT-13.000.58 PL NP-13.802.68 PL Powered by Capital Market - Live News